DK1165112T3 - Modulatorer af polysaccharider og anvendelser deraf - Google Patents

Modulatorer af polysaccharider og anvendelser deraf

Info

Publication number
DK1165112T3
DK1165112T3 DK00919594T DK00919594T DK1165112T3 DK 1165112 T3 DK1165112 T3 DK 1165112T3 DK 00919594 T DK00919594 T DK 00919594T DK 00919594 T DK00919594 T DK 00919594T DK 1165112 T3 DK1165112 T3 DK 1165112T3
Authority
DK
Denmark
Prior art keywords
glycosaminoglycan
peptides
sulfate
chitosan
mediated processes
Prior art date
Application number
DK00919594T
Other languages
English (en)
Inventor
Akira Takashima
Mansour Mohamadzadeh
Mark E Mummert
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of DK1165112T3 publication Critical patent/DK1165112T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
DK00919594T 1999-03-26 2000-03-22 Modulatorer af polysaccharider og anvendelser deraf DK1165112T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12647599P 1999-03-26 1999-03-26

Publications (1)

Publication Number Publication Date
DK1165112T3 true DK1165112T3 (da) 2006-10-09

Family

ID=22425031

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00919594T DK1165112T3 (da) 1999-03-26 2000-03-22 Modulatorer af polysaccharider og anvendelser deraf

Country Status (13)

Country Link
US (2) US6653285B1 (da)
EP (1) EP1165112B1 (da)
JP (1) JP2002540161A (da)
AT (1) ATE328603T1 (da)
AU (1) AU774650B2 (da)
CA (1) CA2366604A1 (da)
CY (1) CY1105531T1 (da)
DE (1) DE60028558T2 (da)
DK (1) DK1165112T3 (da)
ES (1) ES2265928T3 (da)
MX (1) MXPA01009690A (da)
PT (1) PT1165112E (da)
WO (1) WO2000057896A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1430302A4 (en) * 2001-03-21 2007-08-22 Univ Texas Glycosaminoglycan INHIBITORS
US20040259783A1 (en) * 2001-11-09 2004-12-23 Tony Cruz Pharmaceutical compositions of marine sponge microciona prolifera
ITPD20020003A1 (it) * 2002-01-11 2003-07-11 Fidia Advanced Biopolymers Srl Biomateriali a base di acido ialuronico come terapia anti-angiogenicanella cura dei tumori.
US20060198800A1 (en) * 2003-08-14 2006-09-07 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
US20050063932A1 (en) * 2003-08-14 2005-03-24 Natalie Dilallo Skin care compositions including hexapeptide complexes and methods of their manufacture
KR101678925B1 (ko) 2008-06-30 2016-11-24 에스바테크 - 어 노바티스 컴파니 엘엘씨 기능화 폴리펩티드
JP2011526925A (ja) * 2008-07-01 2011-10-20 ザカロン ファーマシューティカルズ，インク． ヘパラン硫酸阻害剤
US8592140B2 (en) 2009-01-02 2013-11-26 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
US9029530B2 (en) * 2009-01-02 2015-05-12 Biomarin Pharmaceutical Inc. Detection of oligosaccharides
US8232073B2 (en) 2009-01-02 2012-07-31 Zacharon Pharmaceuticals, Inc. Quantification of non-reducing end glycan residual compounds
US8809009B2 (en) 2009-01-02 2014-08-19 Biomarin Pharmaceutical Inc. Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
US20130071408A1 (en) * 2010-02-01 2013-03-21 Atul J. Butte Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes Mellitus
PL3249662T3 (pl) * 2016-05-27 2020-11-16 Hanning Elektro-Werke Gmbh & Co. Kg Silnik elektryczny do napędu pompy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207949D0 (en) * 1992-04-09 1992-05-27 Univ Manitoba Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
US5981478A (en) * 1993-11-24 1999-11-09 La Jolla Cancer Research Foundation Integrin-binding peptides
CA2237051A1 (en) 1997-12-19 1999-06-19 Eva A. Turley Enhanced affinity hyaluronan binding peptides
EP1324765A1 (en) * 2000-10-05 2003-07-09 Transition Therapeutics Inc. Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans

Also Published As

Publication number Publication date
CA2366604A1 (en) 2000-10-05
WO2000057896A1 (en) 2000-10-05
CY1105531T1 (el) 2010-07-28
MXPA01009690A (es) 2003-06-24
US20040138105A1 (en) 2004-07-15
JP2002540161A (ja) 2002-11-26
PT1165112E (pt) 2006-10-31
EP1165112A1 (en) 2002-01-02
EP1165112A4 (en) 2002-09-25
ATE328603T1 (de) 2006-06-15
US6923965B2 (en) 2005-08-02
ES2265928T3 (es) 2007-03-01
US6653285B1 (en) 2003-11-25
AU4025500A (en) 2000-10-16
AU774650B2 (en) 2004-07-01
DE60028558D1 (de) 2006-07-20
EP1165112B1 (en) 2006-06-07
DE60028558T2 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
CY1105531T1 (el) Ρυθμιστες πολυσακχαριδιων και χρησεις αυτων
ES2619181T3 (es) Hidrogel quirúrgico
DE69533370D1 (de) Heparinähnliche sulfatierte Polysaccharide
DE69928952D1 (de) Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
ATE426805T1 (de) Verfahren und produkte, die mit niedermolekularem heparin assoziiert sind
WO2007070547A3 (en) Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
AR051676A1 (es) Composiciones oftalmicas que comprenden polimeros sustituidos con polieter
BR9811260A (pt) Pequenas moléculas úteis no tratamento de doença inflamatória
BRPI0418384A (pt) composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
ATE481478T1 (de) Rationell konstruierte, von chondroitinase b abgeleitete lyasen
EA200000911A1 (ru) Новые кристаллические формы антивирусного соединения бензимидазола
BRPI0516568A (pt) biomateriais consistindo em ácido hialurÈnico sulfatado e gelana, bem como composição farmacêutica e uso dos mesmos
SE9602931L (sv) Ny medicinsk användning
PT1216256E (pt) Antibioticos macrolidos e tratamento de pasteurelose
BR0012087A (pt) Composições compreendendo copolìmeros em bloco hidrogenados e aplicações de uso final dos mesmos
BR9508323A (pt) Uso de quitosan e um polissacarídeo imobilizado no mesmo escolhido dentre heparina sulfato de herpan e sulfato de extran e processo para impedir ou reduzir substancialmente a adesão indesejável de tecidos com relação à cicatrização de feridas
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
DE69316758D1 (de) Selbstvernetztes gellangummi
PT804465E (pt) Novos inibidores da elastase
JP2004511492A5 (da)
ATE404208T1 (de) Uridin-therapie für patienten mit erhöhten purin- werten
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
TR200001682T2 (tr) Değiştirilmiş biyolojik tanınma gösteren değiştirilmiş polisakaridler
WO2002076173A3 (en) Inhibitors of glycosaminoglycans
NO20012849D0 (no) Ny terapeutisk anvendelse for hepariner med lav molekylvekt